Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Human Cloning Policy Institute Spearheads Global Grassroots Effort to Prevent Therapeutic Cloning Ban at the United Nations

06.11.2003


The Human Cloning Policy Institute (HCPI) launched this week a major grassroots effort to head off a proposed ban on therapeutic cloning in the United Nations scheduled for vote this Thursday. The total ban is sponsored by Costa Rica and is supported by the United States. The Human Cloning Policy Institute is backed by Ian Wilmut (Dolly’s cloner), some of the world’s leading scientists, physicians and international law experts, including retired World Court judge, C.G. Weeramantry.

HCPI executive director, Bernard Siegel stated, “It is the widespread belief of leading scientists and medical researchers that failure to proceed with SCNT stem cell research is the equivalent to turning our backs on one of the greatest potential medical advances of our time and would thereby destroy the hope for understanding and treatment of many deadly diseases and conditions. A consequence of banning SCNT research might be to condemn millions of adults and children to premature death or a life of intense misery and suffering.”

HCPI has urged its supporters and allied organizations, including disease advocates, private citizens, members of biotechnology organizations, physicians, lawyers and members of the scientific research community, to support passage of UN initiatives outlawing human reproductive cloning, but which allow for the promise of SCNT. It opposes the Costa Rican proposed convention, which bans SCNT research and urges support for the rival Belgium compromise convention, which encourages member states to ban reproductive cloning, but would not ban SCNT internationally.



HCPI further urges support for the World Court Initiative asking the General Assembly to seek an advisory opinion from the International Court of Justice declaring human reproductive cloning (only) a crime against humanity. Siegel stated, “By sponsoring the World Court Initiative, HCPI seeks that the World Court strip away any vestige of legitimacy from potential human cloners, such as Zavos and Antinori. A declaration that human reproductive cloning is a crime against humanity will prompt all member states to crack down on those activities and serve as a lasting deterrent.”

Siegel further commented, “Human reproductive cloning activities performed by unscrupulous scientists are human experimentation. No individual scientist, corporation, business enterprise or nation has the moral or legal warrant to clone human beings. It is extremely important to recognize the difference between reproductive and therapeutic cloning. Informed scientific opinion worldwide supports therapeutic cloning of stem cells. The American Medical Association, the National Academy of Sciences, the Association of American Universities, and many other medical, scientific, and educational associations endorse therapeutic cloning.”

Supporters of HCPI have been urged to email the UN missions at mission@un.org, to express their views on the current proposals. Organizations allied with HCPI on this initiative include the Stem Cell Action Network (SCAN) which has emailed a petition to all UN missions, signed by 2,200 teachers and scientists in medical schools and university science departments across the United States in favor of therapeutic cloning research. The Committee for Advancement of Stem Cell Research (CASCR) also supports the initiative. Both organizations are members of the Coalition for the Advancement of Medical Research.

Frank Cocozzelli, CASCR executive director, who suffers from a form of muscular dystrophy said, “Along with millions of other world citizens who are disabled, suffering from a catastrophic illness or both, SCNT offers me one of the first real rays of hope of being healed.”

The Human Cloning Policy Institute (HCPI) is a nonprofit organization dedicated to advocacy, education and policies against reproductive cloning, while preserving SCNT (therapeutic cloning) which holds the promise of understanding and treating some of man’s deadliest diseases.

HCPI’s principal supporters are leading stem cell scientists, researchers and physicians, who are members of the group’s science and medical advisory boards. A partial list includes: Dr. Ian Wilmut (Roslin Institute), Dr. Rudolf Jaenisch (Whitehead Institute- MIT), Dr. Douglas Melton (Harvard), Dr. Lawrence Goldstein (UCSD), Dr. Gerald Schatten (Magee College), Dr. Alan Trounson ( Monash- Australia), Camillo Ricordi, MD (Diabetes Research Institute), Dr. Helena Edlund (Sweden), Dr. W.Dalton Dietrich (Miami Project to Cure Paralysis), Joe Massey, MD. (Reproductive expert-Atlanta), Judith Grossberg, M.D. (pediatrics-MCV),Doris Rapp, MD ( best-selling author), Sidney Ikpe (International Hospital Relief Foundation), Torrey Brown, MD (Intralytix, Inc., Baltimore) and Dr. Barry Smernoff (Cleveland).

HCPI also has the support of a human rights-legal advisory board that includes retired World Court Judge Christopher Weeramantry (Sri Lanka), law professor Richard Falk (Princeton-UCSB), Peter Ludwig (Darby & Darby-New York) and Nihal Jayawickrama (University of London, School of Economics).

Bernard Siegel | alfa
Further information:
http://www.clonelaw.org

More articles from Health and Medicine:

nachricht Shipment tracking for "fat parcels" in the body
14.10.2019 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Antibody-based eye drops show promise for treating dry eye disease
14.10.2019 | University of Illinois at Chicago

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Solving the mystery of quantum light in thin layers

A very special kind of light is emitted by tungsten diselenide layers. The reason for this has been unclear. Now an explanation has been found at TU Wien (Vienna)

It is an exotic phenomenon that nobody was able to explain for years: when energy is supplied to a thin layer of the material tungsten diselenide, it begins to...

Im Focus: An ultrafast glimpse of the photochemistry of the atmosphere

Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich have explored the initial consequences of the interaction of light with molecules on the surface of nanoscopic aerosols.

The nanocosmos is constantly in motion. All natural processes are ultimately determined by the interplay between radiation and matter. Light strikes particles...

Im Focus: Shaping nanoparticles for improved quantum information technology

Particles that are mere nanometers in size are at the forefront of scientific research today. They come in many different shapes: rods, spheres, cubes, vesicles, S-shaped worms and even donut-like rings. What makes them worthy of scientific study is that, being so tiny, they exhibit quantum mechanical properties not possible with larger objects.

Researchers at the Center for Nanoscale Materials (CNM), a U.S. Department of Energy (DOE) Office of Science User Facility located at DOE's Argonne National...

Im Focus: Novel Material for Shipbuilding

A new research project at the TH Mittelhessen focusses on the development of a novel light weight design concept for leisure boats and yachts. Professor Stephan Marzi from the THM Institute of Mechanics and Materials collaborates with Krake Catamarane, which is a shipyard located in Apolda, Thuringia.

The project is set up in an international cooperation with Professor Anders Biel from Karlstad University in Sweden and the Swedish company Lamera from...

Im Focus: Controlling superconducting regions within an exotic metal

Superconductivity has fascinated scientists for many years since it offers the potential to revolutionize current technologies. Materials only become superconductors - meaning that electrons can travel in them with no resistance - at very low temperatures. These days, this unique zero resistance superconductivity is commonly found in a number of technologies, such as magnetic resonance imaging (MRI).

Future technologies, however, will harness the total synchrony of electronic behavior in superconductors - a property called the phase. There is currently a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

International Symposium on Functional Materials for Electrolysis, Fuel Cells and Metal-Air Batteries

02.10.2019 | Event News

NEXUS 2020: Relationships Between Architecture and Mathematics

02.10.2019 | Event News

Optical Technologies: International Symposium „Future Optics“ in Hannover

19.09.2019 | Event News

 
Latest News

Quantum physics: Ménage à trois photon-style

16.10.2019 | Physics and Astronomy

Airborne chemicals instantly identified using new technology developed at NTU Singapore

16.10.2019 | Life Sciences

Always on beat: ultrashort flashes of light under optical control

16.10.2019 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>